Article Information
History
- March 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Marcelo Silva1,*,
- Andrés Espejo1,
- María L Pereyra1,
- Martín Lynch1,
- Marcos Thompson1,
- Hernán Taconelli2,
- Patricia Baré3,
- Matías J Pereson3,
- Marcelo Garbini4,
- Pablo Crucci4 and
- Diego Enriquez4
- 1Unidad de Hepatología y Trasplante Hepático, Hospital Universitario Austral, Pilar, Argentina
- 2Sanatorio Nuestra Señora del Pilar, Ciudadela, Argentina
- 3IIHEMA, IMEX-CONICET, Academia Nacional de Medicina
- 4Departamento de Investigación Clínica, Laboratorios Roemmers
- ↵*Corresponding author:
Prof. Marcelo Silva, MD. Director de la Unidad de Hepatología y Trasplante Hepático, Hospital Universitario Austral, Pilar, Argentina Av. J. D. Perón 1500 (1629). Derqui, Provincia de Buenos Aires, Argentina., e-mail: msilva{at}cas.austral.edu.ar
Posted March 05, 2021.
Efficacy of Nitazoxanide in reducing the viral load in COVID-19 patients. Randomized, placebo-controlled, single-blinded, parallel group, pilot study.
